Latest News and Press Releases
Want to stay updated on the latest news?
-
Tilgin Delårsrapport 1 januari - 30 september 2007 Tredje kvartalet 2007 • Nettoomsättning 89,9 mkr (86,6). • Resultat efter skatt -5,2 mkr (-7,2), varav utfall och omvärderingar av valutasäkringar...
-
Interim Report for New Wave Group AB (publ) January-September 2007 Continued strong growth in profit. THE PERIOD JANUARY 1 - SEPTEMBER 30 2007 COMPARED TO PRECEDING YEAR. - Sales increased by 17 %...
-
DELÅRSRAPPORT för New Wave Group AB (publ) Januari-september 2007 Fortsatt stark resultattillväxt PERIODEN 1 JANUARI - 30 SEPTEMBER 2007 JÄMFÖRT MED FÖREGÅENDE ÅR. - Omsättningen ökade med 17 % till...
-
Tilgin Interim report 1 January - 30 September 2007 Third quarter 2007 • Net sales SEK 89.9 million (86.6). • Net result SEK -5.2 million (-7.2), of which realized and unrealized currency hedging...
-
Bruxelles, le 26 octobre à 7:00 am CET - Les essais cliniques de Phase III de l'anti-épileptique en développement, brivaracetam, sont en cours afin de tester le médicament dans le cadre d'un...
-
Brussels (BELGIUM), October 26, 2007 at 7:00 am CET - Phase III clinical trials of UCB's antiepileptic drug (AED) in development, brivaracetam, are underway, as adjunctive therapy in patients with...
-
Brussel, 26 oktober 2007 om 7:00 am CET - De fase III klinische studies van brivaracetam, een anti-epilepticum dat door UCB wordt ontwikkeld als adjunctieve behandeling van refractaire epilepsie met...
-
Die weltweit im Technologie- und Systembereich sowie im Komponentengeschäft tätige Lysser Feintool-Gruppe arbeitet zur Zeit am Jahresabschluss 2006/07 für das am 30. September 2007 abgeschlossene...
-
The Feintool Group, a leading technology and systems provider and global components supplier based in Lyss (Switzerland) is currently preparing the financial statements for the 2006/07 financial year,...
-
YIT CORPORATION CORPORATE RELEASE INTERIM REPORT OCT. 26, 2007 at 8:00 YIT'S INTERIM REPORT: JANUARY 1 -...